Breast MRI Illuminates Risk of Second Breast Cancer (IMAGE)
Caption
Postoperative surveillance images in a 54-year-old woman who had undergone right breast–conserving surgery and postoperative radiation therapy 2 years prior for stage III hormone receptor–positive invasive ductal carcinoma. She had completed adjuvant chemotherapy and was on endocrine therapy. She had no family history of breast cancer and had not been tested for the BRCA1/2 genes. (A) Bilateral sagittal contrast-enhanced T1-weighted and (B) maximum intensity projection images from baseline surveillance breast MRI show asymmetric moderate background parenchymal enhancement in the left breast. (C) Surveillance mammograms acquired within 6 months of surveillance breast MRI show heterogeneously dense breasts. (D) Subsequent surveillance breast MRI scans acquired 2 years after baseline surveillance breast MRI show a small irregular enhancing mass in the left upper breast (arrow). Biopsy and surgical pathologic examination revealed a 0.8-cm ductal carcinoma in situ.
Credit
Radiological Society of North America
Usage Restrictions
May use with credit.
License
Licensed content